Article
Randomized controlled trial of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation.
Journal of clinical pharmacy and therapeutics - 1 Dec 2020
Zhu Ye, Xu Chao, Liu Jia
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Warfarin is an oral anticoagulant which has been widely used to treat and prevent thromboembolic events. Managing warfarin therapy requires careful monitoring and dose titration. This randomized controlled study was designed to assess the effect of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation. METHODS: 507 adults were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
